CIK 0001408443 · Non-accelerated filer<br>Smaller reporting company
Milestone Pharmaceuticals Inc.
Sign in to watch- Ticker
- MIST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Quebec, Canada
- Entity type
- operating
- Phone
- (514) 336-0444
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- 4 Open-market sale Chief Operating Officer sold 70,252 shares at an average $2.25 ($158,209)
- 4 Open-market sale Chief Commercial Officer sold 64,746 shares at an average $2.25 ($145,851)
- 4 Open-market sale CFO & EVP of Corp. Development sold 70,252 shares at an average $2.25 ($158,209)
- 4 Open-market sale President and CEO sold 167,577 shares at an average $2.24 ($375,315)
- 4 Planned sale President and CEO sold 43,500 shares at $2.25 ($97,875)
- 4 Gift Chief Commercial Officer gave 25,000 shares (gift)
- 4 Grant or award Director acquired 16,666 shares (grant or award)
- 4 Grant or award CFO & EVP of Corp. Development acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 53,333 shares (grant or award)
- 4 Grant or award President and CEO acquired 66,666 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 66,666 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 8 · 158 filings